Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCKBR | P32239 | 10/20 | 0.61 |
| ▸ | CCKAR | P32238 | 4/20 | 0.60 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.60 |
| ▸ | KISS1R | Q969F8 | 2/20 | 0.58 |
| ▸ | GRPR | P30550 | 2/20 | 0.55 |
| ▸ | NPBWR1 | P48145 | 1/20 | 0.53 |
| ▸ | MC4R | P32245 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18556749 | 0.99 | CCKBR (0.61) | CCKBRCCKAROPRD1KISS1RGRPR | |
| SCHEMBL12094758 | 0.94 | MC4R (0.59) | CCKBRCCKAROPRD1KISS1RNPBWR1 | |
| SCHEMBL16677035 | 0.94 | MC4R (0.59) | CCKBRCCKAROPRD1KISS1RNPBWR1 | |
| SCHEMBL18556707 | 0.94 | MC4R (0.59) | CCKBRCCKAROPRD1KISS1RNPBWR1 | |
| SCHEMBL18891478 | 0.94 | MC4R (0.59) | CCKBRCCKAROPRD1KISS1RNPBWR1 | |
| SCHEMBL18891547 | 0.94 | MC4R (0.59) | CCKBRCCKAROPRD1KISS1RNPBWR1 | |
| SCHEMBL12094756 | 0.94 | CCKBR (0.56) | CCKBRCCKAROPRD1KISS1R | |
| SCHEMBL18891548 | 0.92 | MC4R (0.62) | CCKBRKISS1RMC4R | |
| SCHEMBL18891483 | 0.92 | MC4R (0.62) | CCKBRKISS1RMC4R | |
| SCHEMBL18556747 | 0.91 | CCKBR (0.58) | CCKBRCCKAROPRD1NPBWR1MC4R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170145056-A1 | Melanocortin-1 Receptor-Specific Linear Peptides | PALATIN TECHNOLOGIES INC (US) | 2017-05-25 | — | — | US | disclosed |
| US-9580466-B2 | Melanocortin-1 receptor-specific linear peptides | PALATIN TECHNOLOGIES, INC. (US) | 2017-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170145056-A1 | Melanocortin-1 Receptor-Specific Linear Peptides | MC1R, MC5R, MC3R | CCKBR 71/4885CCKAR 26/4885OPRD1 406/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.